CAJ | 학술논문

目的:探讨替米沙坦对高血压前期伴危险因素患者脉搏波传导速度(PWV)和踝臂指数(ABI)的影响.方法:165例高血压前期(SBP130mmHg≤SBP≤140mmHg和/或DBP85mmHg≤DBP≤90mmHg)伴危险因素患者,随机分为对照组80例和治疗组85例,治疗12个月后,观察治疗前后血压,PWV,ABI的变化.结果:与对照组相比,治疗组血压,PWV较治疗前明显降低,ABI增加.结论:替米沙坦可减少高血压前期伴危险因素的血压和PWV,增加ABI.
목적:탐토체미사탄대고혈압전기반위험인소환자맥박파전도속도(PWV)화과비지수(ABI)적영향.방법:165례고혈압전기(SBP130mmHg≤SBP≤140mmHg화/혹DBP85mmHg≤DBP≤90mmHg)반위험인소환자,수궤분위대조조80례화치료조85례,치료12개월후,관찰치료전후혈압,PWV,ABI적변화.결과:여대조조상비,치료조혈압,PWV교치료전명현강저,ABI증가.결론:체미사탄가감소고혈압전기반위험인소적혈압화PWV,증가ABI.
@@@@Objective:To explore telmisartan prehypertension associated with patients with risk factors for pulse wave velocity(PWV) and ankle-brachial index(ABI). Methods:Associated with risk factors for 165 patients with prehypertension (SBP130mmHg≤ SBP ≤ 140mmHg and / or DBP85mmHg ≤ DBP ≤ 90 mmHg) were randomly divided into 85 cases of 80 cases of the control group and treatment group, after 12 months of treatment, blood pressure, PWV were observed before and after treatmentABI change. Results:Significantly reduced compared with control group, the blood pressure in the treatment group, the PWV in than before treatment, ABI increased.Conclusion:Telmisartan may reduce blood pressure and PWV prehypertension with risk factors increase the ABI.